Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=vrtxLatest Financial News for Vertex Pharmaceuticals Incorporen-usSat, 19 Dec 2009 10:49:41 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vaerrqt/*http%3A//online.barrons.com/article/SB126118058546197817.html?ru=yahoo&mod=yahoobarronsResearch Reports Comments from investment analysts on several companies, each with buy/hold/sell recommendations.yahoo_finance/3522714759Sat, 19 Dec 2009 10:49:41 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ibd/091217/newamer.html?.v=1China's factories churn out inexpensive water pumps, photovoltaic solar cells and knockoff iPods.yahoo_finance/280088402Thu, 17 Dec 2009 22:28:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12ubcsip1/*http%3A//www.fool.com/investing/general/2009/12/17/this-just-in-upgrades-and-downgrades.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3884518429Thu, 17 Dec 2009 18:55:58 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_anadys_pharmaceuticals_study.html?.v=1Anadys Pharmaceuticals Inc. said Thursday its experimental hepatitis C drug is meeting key goals in a midstage clinical trial.yahoo_finance/3543586607Thu, 17 Dec 2009 16:15:48 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_achillion_pharmaceuticals_mover.html?.v=1Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive "proof-of-concept" results, while meeting safety and tolerability goals in an early-stage study.yahoo_finance/3423123691Wed, 16 Dec 2009 19:33:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh02164_2009-12-16_16-37-29_sge5bf0ho_newsml&rpc=44&type=marketsNewsyahoo_finance/3501159521Wed, 16 Dec 2009 16:37:29 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28374.html?.v=1Human Genome announced the submission of a Marketing Authorization Application to the EMEA seeking marketing approval of Joulferon.yahoo_finance/3120527927Wed, 16 Dec 2009 16:20:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=132c2camq/*http%3A//www.fool.com/investing/high-growth/2009/12/14/this-just-in-upgrades-and-downgrades.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/595656279Mon, 14 Dec 2009 20:03:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091214/28267.html?.v=2yahoo_finance/473648507Mon, 14 Dec 2009 14:54:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091210/20091210005071.html?.v=1CAMBRIDGE, Mass.----Vertex Pharmaceuticals Incorporated today announced the appointment of Nancy J. Wysenski as Executive Vice President and Chief Commercial Officer. Ms. Wysenski has more than 30 years of experience in building commercial operations and in developing and implementing sales and marketing activities for major pharmaceutical products.yahoo_finance/435905408Thu, 10 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12785bp0s/*http%3A//boston.bizjournals.com/boston/stories/2009/12/07/daily5.html?ana=yfcpcyahoo_finance/3963328514Mon, 7 Dec 2009 17:05:29 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091204/vrtx8-k.htmlyahoo_finance/1693208092Fri, 4 Dec 2009 21:31:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091204/us_vertex_pharmaceuticals_offering.html?.v=1Vertex Pharmaceuticals Inc. on Friday said underwriters exercised their option to buy additional stock in a previously announced $442.8 million offering.yahoo_finance/3694094290Fri, 4 Dec 2009 15:16:58 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091204/20091204005095.html?.v=1CAMBRIDGE, Mass.----Vertex Pharmaceuticals Incorporated today announced that the underwriters of its public offering have exercised in full their option to purchase an additional 1,500,000 shares of common stock at the public offering price of $38.50 per share.yahoo_finance/3371262220Fri, 4 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091202/us_vertex_pharma_stock_sale.html?.v=4Vertex Pharmaceuticals Inc. late Wednesday expanded its public stock offering to 11.5 million shares from 10 million, priced at $38.50 each for gross proceeds of $442.8 million.yahoo_finance/2366197658Thu, 3 Dec 2009 03:59:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091202/20091202006543.html?.v=1CAMBRIDGE, Mass.----Vertex Pharmaceuticals Incorporated today announced that it has entered into an agreement to sell 11,500,000 shares of its common stock in an underwritten offering at a price to the public of $38.50 per share, which would result in aggregate gross proceeds of $442.8 million.yahoo_finance/1180535069Thu, 3 Dec 2009 03:52:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128f3qpl7/*http%3A//boston.bizjournals.com/boston/stories/2009/11/30/daily46.html?ana=yfcpcyahoo_finance/2722211534Wed, 2 Dec 2009 22:05:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12trah90n/*http%3A//www.thestreet.com/_yahoo/story/10637228/1/vertex-raising-money--again-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1285807975Wed, 2 Dec 2009 21:30:11 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091202/20091202006398.html?.v=1CAMBRIDGE, Mass.----Vertex Pharmaceuticals Incorporated today announced that it intends to offer, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering under an effective shelf registration statement on file with the Securities and Exchange Commission.yahoo_finance/1494691135Wed, 2 Dec 2009 21:07:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=131gjskan/*http%3A//www.fool.com/investing/high-growth/2009/12/01/great-call-on-mgm-mirage-whats-next.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2922281567Tue, 1 Dec 2009 21:01:41 Etc/GMT